It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Treatment failure in joint infections is associated with fibrinous, antibiotic-resistant, floating and tissue-associated Staphylococcus aureus aggregates formed in synovial fluid (SynF). We explore whether antibiotic activity could be increased against Staphylococcus aureus aggregates using ultrasound-triggered microbubble destruction (UTMD), in vitro and in a porcine model of septic arthritis. In vitro, when bacterially laden SynF is diluted, akin to the dilution achieved clinically with lavage and local injection of antibiotics, amikacin and ultrasound application result in increased bacterial metabolism, aggregate permeabilization, and a 4-5 log decrease in colony forming units, independent of microbubble destruction. Without SynF dilution, amikacin + UTMD does not increase antibiotic activity. Importantly, in the porcine model of septic arthritis, no bacteria are recovered from the SynF after treatment with amikacin and UTMD—ultrasound without UTMD is insufficient. Our data suggest that UTMD + antibiotics may serve as an important adjunct for the treatment of septic arthritis.
Coupling ultrasound-triggered microbubble destruction with antibiotics in diluted synovial fluid leads to the effective clearance of S. aureus in models of septic arthritis
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details













1 Thomas Jefferson University, Department of Orthopaedic Surgery, Sidney Kimmel College, Philadelphia, USA (GRID:grid.265008.9) (ISNI:0000 0001 2166 5843)
2 Thomas Jefferson University, Department of Radiology, Philadelphia, USA (GRID:grid.265008.9) (ISNI:0000 0001 2166 5843)
3 University of Pennsylvania, Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, Kennett Square, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
4 Rothman Orthopaedic Institute, Philadelphia, USA (GRID:grid.512234.3) (ISNI:0000 0004 7638 387X)
5 Brigham and Women’s Hospital, Harvard Medical School, Department of Orthopaedic Surgery, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)
6 Thomas Jefferson University, Department of Orthopaedic Surgery, Sidney Kimmel College, Philadelphia, USA (GRID:grid.265008.9) (ISNI:0000 0001 2166 5843); Rothman Orthopaedic Institute, Philadelphia, USA (GRID:grid.512234.3) (ISNI:0000 0004 7638 387X)